Questions | Reviews
I AM NEEDING TO KNOW HOW MANY BREATHING TREATMENTS I CAN DO IN A 24 HOUR PERIOD.
by GOLDENA L HICKERSON in SACRAMENTO, CA, 03/30/2009
What is the maximum dose for MDI albuterol?
by brian in salt lake city, ut, 03/03/2009
Two ow did the insurance QuotesChimp beginning? Why don't we stage back for some time and review these thrilling (and uncertain) times of yester-year, before policy contract was devised, prior to what &number3 4;possess a slice of the stone&number3 4;...
by Lilian in Lilian, 03/06/2014
my granddaughter age 4 and one half has to use albuterol when she starts to have coughing spells. She becomes nasty and bilergent. When she is wheened off the med, she becomes bad. Yesterday she put a push pen in her best friend in day care. She kept ...
by anita kohler in philadelphia, pa, 01/06/2006
FINALLY someone being hosent about this issue! I wish that there was a magic pill to cure alsheimers (sp.?) disease. But never do they talk about the basics of being involved and feeling needed plus diet. I dont know if she mentioned it, but also I th...
by Pinky in Pinky, 01/12/2014
Classification: Direct-acting adrenergic (sympathomimetic) agent
See Also: See also Sympathomimetic Drugs.
Action/Kinetics: Stimulates beta-2 receptors of the bronchi, leading to bronchodilation. Causes less tachycardia and is longer-acting than isoproterenol. Has minimal beta-1 activity. Available as an inhaler that contains no chlorofluorocarbons (Proventil HFA). Onset, PO: 15-30 min; inhalation, within 5 min. Peak effect, PO: 2-3 hr; inhalation, 60-90 min (after 2 inhalations). Duration, PO: 4-8 hr (up to 12 hr for extended-release); inhalation, 3-6 hr. Metabolites and unchanged drug excreted in urine and feces. Do not use tablets in children less than 12 years of age.
Uses: Bronchial asthma; bronchospasm due to bronchitis or emphysema; bronchitis; children 4 years and older for treatment or prevention of bronchospasm with reversible obstructive pulmonary disease; exercise-induced bronchospasm, including those 4 years of age and older. Prophylaxis of bronchial asthma or bronchospasms. Parenteral for treatment of status asthmaticus. Proventil HFA may be used in clients 4 years of age and older. Investigational: Nebulized albuterol may be useful as an adjunct to treat serious acute hyperkalemia in hemodialysis clients.
Contraindications: Aerosol for prevention of exercise-induced bronchospasm is not recommended for children less than 12 years of age. Use during lactation.
Special Concerns: Dosage has not been established for the syrup and solution for inhalation in children less than 2 years of age, for tablets and extended-release tablets in children less than 6 years of age, and the aerosol and inhalation powder in children less than 4 years of age. Albuterol may delay preterm labor. Large IV doses may aggravate preexisting diabetes mellitus and ketoacidosis.
Additional Side Effects: GI: Diarrhea, dry mouth, appetite loss or stimulation, epigastric pain. CNS: Hyperkinesia, excitement, nervousness, tension, tremor, dizziness, vertigo, weakness, drowsiness, restlessness, headache, insomnia, malaise, emotional lability, fatigue, lightheadedness, nightmares, disturbed sleep, aggressive behavior, irritability. Respiratory: Cough, wheezing, dyspnea, bronchospasm, dry throat, pharyngitis, throat irritation, bronchitis, epistaxis, hoarseness (especially in children), nasal congestion, increase in sputum. CV: Palpitations, tachycardia, BP changes, hypertension, tight chest, chest pain or discomfort, angina. Hypersensitivity (may be immediate): Urticaria, angioedema rash, bronchospasm. Miscellaneous: Flushing, sweating, bad or unusual taste, change in smell, muscle cramps, pallor, teeth discoloration, conjunctivitis, dilated pupils, difficulty in urination, muscle spasm, voice changes, oropharyngeal edema.
Symptoms: Seizures, anginal pain, hypertension, hypokalemia, tachycardia (rate may increase to 200 beats/min).
Metered dose inhaler: 0.09 mg/inh;
Capsule: 200 mcg;
Solution: 0.083%, 0.5%;
Syrup: 2 mg/5 mL;
Tablet: 2 mg, 4 mg;
Tablet, Extended Release: 4 mg, 8 mg
How Supplied: Metered dose inhaler: 0.09 mg/inh; Capsule: 200 mcg; Solution: 0.083%, 0.5%; Syrup: 2 mg/5 mL; Tablet: 2 mg, 4 mg; Tablet, Extended Release: 4 mg, 8 mg